Abstract MANY the more frequently performed surgical procedures for malignant disease of the head and neck require blood transfusion.1 Homologous blood transfusion carries with it the well-known hazards of homologous serum jaundice and transfusion reactions. Under certain circumstances, compatible blood may be difficult to obtain. The most desirable blood for transfusion would be that of the patient himself. Recently, such autologous blood transfusions (autotransfusions) have been used in elective orthopedic,2 cardiovascular,3 and thoracic surgery.4 The modern technique of combined preoperative irradiation followed by surgery for malignant lesions of the head and neck offers a unique opportunity to utilize autologous transfusions.5-7 These patients are treated with several thousand rads of well-collimated cobalt60 teletherapy over a period of one to three weeks, followed by a variable waiting period (three to six weeks); and then surgery. Autotransfusion has been used since 1964 by the departments of cardiovascular surgery, References 1. Shalom, A.F.: Blood Loss in Ear, Nose, and Throat Operations , J Laryng 78:734-756 ( (Aug) ) 1964.Crossref 2. Turner, R.S.: Autologous Blood Transfusions, read before the American Academy of Orthopedic Surgery, Chicago, January 1968. 3. Cuello, L., et al: Autologous Blood Transfusion in Cardiovascular Surgery , Transfusion 7:309-315 ( (July) -Aug) 1967.Crossref 4. Miles, G.; Langton, H.; and Dalessandro, W.: Experiences With Autotransfusions , Surg Gynec Obstet 115:689-694 ( (Dec) ) 1962. 5. Goldman, J., et al: Combined Radiation and Surgical Therapy for Carcinoma of the Larynx and Laryngopharynx , Laryngoscope 74:1111-1134 ( (Aug) ) 1964.Crossref 6. Hudson, W.R., and Cavanaugh, P.J.: Combined Surgical and Radiation Management of Carcinoma of the Laryngopharynx , Laryngoscope 75:1123-1138 ( (July) ) 1965.Crossref 7. Reed, G.F.: Pre-Operative Irradiation and Laryngeal Carcinoma , Arch Otolaryng 86:318-325 ( (Sept) ) 1967.Crossref 8. Wintrobe, M.: Clinical Hematology , Philadelphia: Lea and Febiger, 1961, pp 461-475. 9. Brown, E.B., et al: Intravenously Administered Saccharated Iron Oxide in the Treatment of Hypochromic Anemia , JAMA 144:1084-1089 ( (Nov 25) ) 1950.Crossref 10. Finch, S.; Haskins, D.; and Finch, C.A.: Iron Metabolism, Hematopoiesis Following Phlebotomy: Iron as a Limiting Factor , J Clin Invest 29:1078-1086 ( (Aug) ) 1950.Crossref 11. Tullis, J.L.: in Bishop, C., and Surgenor, D.M. (eds.): The Red Blood Cells , New York: Academic Press, Inc., 1964, p 491.
Archives of Otolaryngology – American Medical Association
Published: Oct 1, 1968